EPISODE · Jan 15, 2026 · 26 MIN
Early Cancer Detection and the Critical Role of Workplace Screening
from Talking Health and Wellbeing: The amii Podcast · host amii
In this episode, Dave Middleton, Executive Chair of amii, talks with Professor Gordon Wishart, Founder and CEO of Check4Cancer, about the growing challenge of cancer in the UK workforce. Professor Wishart, who spent many years running the breast unit in Cambridge, explains how cancer incidence continues rising due to an ageing population and increasingly unhealthy lifestyles, yet infrastructure for diagnosis and treatment hasn't kept pace. The result is longer waits, later diagnoses, and poorer survival outcomes, with GPs effectively forced into a rationing role that delays access to diagnostic services.The podcast explores why cancer screening remains the most sought-after employee benefit across all generations. Dave recounts an unexpected moment years ago when an employee, having just disclosed their cancer diagnosis, immediately worried about financial security—a conversation that caught him completely unprepared. Professor Wishart outlines the three pillars of effective early detection: education about signs and symptoms; prevention through screening programmes; and rapid diagnosis pathways. He discusses Check4Cancer's My Cancer Risk platform, which identifies the highest-risk 20% of employees for funded screening, with companies typically seeing 40% workforce engagement and 70% screening uptake amongst those at higher risk.The discussion explores lifestyle factors, with Professor Wishart noting that 40% of UK cancers are preventable. Obesity emerges as a particular concern for bowel and post-menopausal breast cancer, whilst the conversation touches on ultra-processed foods and their possible link to rising cancer rates in younger people. When Dave questions whether risks of weight-loss medications outweigh their benefits, Professor Wishart argues that for those with severe obesity, the risk of doing nothing likely exceeds medication concerns. The episode concludes with recognition that cancer screening has moved from nice-to-have to essential workforce management, as employers increasingly fill gaps left by stretched NHS capacity.
What this episode covers
In this episode, Dave Middleton, Executive Chair of amii, talks with Professor Gordon Wishart, Founder and CEO of Check4Cancer, about the growing challenge of cancer in the UK workforce. Professor Wishart, who spent many years running the breast unit in Cambridge, explains how cancer incidence continues rising due to an ageing population and increasingly unhealthy lifestyles, yet infrastructure for diagnosis and treatment hasn't kept pace. The result is longer waits, later diagnoses, and poorer survival outcomes, with GPs effectively forced into a rationing role that delays access to diagnostic services.The podcast explores why cancer screening remains the most sought-after employee benefit across all generations. Dave recounts an unexpected moment years ago when an employee, having just disclosed their cancer diagnosis, immediately worried about financial security—a conversation that caught him completely unprepared. Professor Wishart outlines the three pillars of effective early detection: education about signs and symptoms; prevention through screening programmes; and rapid diagnosis pathways. He discusses Check4Cancer's My Cancer Risk platform, which identifies the highest-risk 20% of employees for funded screening, with companies typically seeing 40% workforce engagement and 70% screening uptake amongst those at higher risk.The discussion explores lifestyle factors, with Professor Wishart noting that 40% of UK cancers are preventable. Obesity emerges as a particular concern for bowel and post-menopausal breast cancer, whilst the conversation touches on ultra-processed foods and their possible link to rising cancer rates in younger people. When Dave questions whether risks of weight-loss medications outweigh their benefits, Professor Wishart argues that for those with severe obesity, the risk of doing nothing likely exceeds medication concerns. The episode concludes with recognition that cancer screening has moved from nice-to-have to essential workforce management, as employers increasingly fill gaps left by stretched NHS capacity.
NOW PLAYING
Early Cancer Detection and the Critical Role of Workplace Screening
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m